mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.01 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.003 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.009 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.009 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |